Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/25057276
Conclusion of this study
Pterostilbene increases LDL and reduces blood pressure in adults. This trial is registered with Clinicaltrials.gov NCT01267227.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
 Cardiovascular System |
 Digestive System |
